Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance
Kunal H Bhatt, Rajeev Rudraraju, Jeremy F Brooks, Ji-Won Jung, Ryan Galea, James W Wells, Raymond J Steptoe
STEM CELL RESEARCH & THERAPY | BIOMED CENTRAL LTD | Published : 2017
Awarded by NHMRC
Awarded by Australian Research Council Future Fellowship
Awarded by Australian Research Council
This work was supported by NHMRC Project Grant GNT1013066 (RJS). KHB was supported by a UQ Postdoctoral Fellowship. RJS was a recipient of Australian Research Council Future Fellowship (FT110100372). JWW was supported in part by grants from the Australian Research Council (DP150103714) and by a Perpetual Trustees Fellowship.